Atrandi Biosciences
Series AVilnius, LithuaniaFeb 2025
Atrandi Biosciences raised €24M in a Series A round in Feb 2025. The company is based in Vilnius, Lithuania. Investors in the round: GRIDS Capital, Lux Capital, Metaplanet and 2 others. Data as of Nov 2026.
Amount raised
€24M
€23,960,130
Native amount
25,000,000 USD
Stage
Series A
series a
Investors
5
Provenance & confidence
Low confidenceAmount
25,000,000 USD
ECB-at-date → €24M · rate 1.0434 on 2025-02-19
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Feb 2025
Round type
series a
Amount (EUR)
€24M
Other rounds
same companyThis is the company's only recorded round.